Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.āā⦠read more
Healthcare
Biotechnology
7 years
USD
Exclusive to Premium users
$7.36
Price+2.37%
$0.17
$4.329m
Small
0x
Premium
Premium
-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow Margin$100.370k
-
1y CAGR-
3y CAGR-
5y CAGR-$12.169m
-
1y CAGR-
3y CAGR-
5y CAGR-$41.64
-
1y CAGR-
3y CAGR-
5y CAGR$2.551m
$8.913m
Assets$6.361m
Liabilities-
Debt0.00%
-
Debt to EBITDA-$10.696m
-
1y CAGR-
3y CAGR-
5y CAGR